logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Node+ HR+ breast cancer: chemo may be beneficial despite low RS

Analysis of almost 30,000 women with stage I-III, node-positive disease and RS of 25 or less.